Cargando…
A Novel Proteogenomic Integration Strategy Expands the Breadth of Neo-Epitope Sources
SIMPLE SUMMARY: Tumor-specific antigens are ideal targets for cancer immunotherapy. Mass spectrometry, which is the main method that directly identifies neo-epitopes presented on tumor cells, focuses mainly on peptides derived from annotated protein-coding exomes. However, non-canonical peptides ari...
Autores principales: | Xiang, Haitao, Zhang, Le, Bu, Fanyu, Guan, Xiangyu, Chen, Lei, Zhang, Haibo, Zhao, Yuntong, Chen, Huanyi, Zhang, Weicong, Li, Yijian, Lee, Leo Jingyu, Mei, Zhanlong, Rao, Yuan, Gu, Ying, Hou, Yong, Mu, Feng, Dong, Xuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220843/ https://www.ncbi.nlm.nih.gov/pubmed/35740681 http://dx.doi.org/10.3390/cancers14123016 |
Ejemplares similares
-
ProGeo-neo: a customized proteogenomic workflow for neoantigen prediction and selection
por: Li, Yuyu, et al.
Publicado: (2020) -
Expanding the breadth and depth of Science Advances
por: Shilatifard, Ali
Publicado: (2021) -
The Role of Mass Spectrometry and Proteogenomics in the Advancement of HLA Epitope Prediction
por: Creech, Amanda L., et al.
Publicado: (2018) -
ProGeo-Neo v2.0: A One-Stop Software for Neoantigen Prediction and Filtering Based on the Proteogenomics Strategy
por: Liu, Chunyu, et al.
Publicado: (2022) -
Identification and ranking of recurrent neo-epitopes in cancer
por: Blanc, Eric, et al.
Publicado: (2019)